Metraipolis › archive › dc_4e85fd1e135f

Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial — Europe PMC PMID:41198723

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41198723
DOI
10.1038/s41598-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-08T18:06:24.712Z
SHA-256 of the archived text
bc557cc9b18ab4eaed694a18877f5ffe21c1a74104ece3c8fa77d6a8d8800821
Stable URL of this page
https://metraipolis.com/documento/dc_4e85fd1e135f

How to cite

Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial — Europe PMC PMID:41198723 — Europe PMC (en), https://europepmc.org/article/MED/41198723 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e85fd1e135f (Metraipolis archive dc_4e85fd1e135f, sha256 bc557cc9b18ab4eaed694a18877f5ffe21c1a74104ece3c8fa77d6a8d8800821)
BibTeX
@misc{dc4e85fd1e135f,
  title = {Comparative efficacy and safety of topical caspofungin 0.5% and voriconazole 1% for fungal keratitis: a pilot clinical trial — Europe PMC PMID:41198723},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41198723},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e85fd1e135f; sha256 bc557cc9b18ab4eaed694a18877f5ffe21c1a74104ece3c8fa77d6a8d8800821},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41198723. Agents can read the archived copy with the MCP tool read_document.